Literature DB >> 25868747

Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: A prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000.

Giuseppe Deganutti1, Alberto Cuzzolin1, Antonella Ciancetta1, Stefano Moro2.   

Abstract

The search for G protein-coupled receptors (GPCRs) allosteric modulators represents an active research field in medicinal chemistry. Allosteric modulators usually exert their activity only in the presence of the orthosteric ligand by binding to protein sites topographically different from the orthosteric cleft. They therefore offer potentially therapeutic advantages by selectively influencing tissue responses only when the endogenous agonist is present. The prediction of putative allosteric site location, however, is a challenging task. In facts, they are usually located in regions showing more structural variation among the family members. In the present work, we applied the recently developed Supervised Molecular Dynamics (SuMD) methodology to interpret at the molecular level the positive allosteric modulation mediated by LUF6000 toward the human adenosine A3 receptor (hA3 AR). Our data suggest at least two possible mechanisms to explain the experimental data available. This study represent, to the best of our knowledge, the first case reported of an allosteric recognition mechanism depicted by means of molecular dynamics simulations.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Allosteric modulators; G protein-coupled receptors; Human A(3) adenosine receptor antagonists; Supervised Molecular Dynamics

Mesh:

Substances:

Year:  2015        PMID: 25868747     DOI: 10.1016/j.bmc.2015.03.039

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  19 in total

1.  Coupling Supervised Molecular Dynamics (SuMD) with Entropy Estimations To Shine Light on the Stability of Multiple Binding Sites.

Authors:  Shailesh Kumar Panday; Mattia Sturlese; Veronica Salmaso; Indira Ghosh; Stefano Moro
Journal:  ACS Med Chem Lett       Date:  2019-02-15       Impact factor: 4.345

Review 2.  An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge.

Authors:  Ugo Perricone; Maria Rita Gulotta; Jessica Lombino; Barbara Parrino; Stella Cascioferro; Patrizia Diana; Girolamo Cirrincione; Alessandro Padova
Journal:  Medchemcomm       Date:  2018-04-19       Impact factor: 3.597

3.  Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.

Authors:  Antonella Ciancetta; Kenneth A Jacobson
Journal:  Methods Mol Biol       Date:  2018

4.  Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors.

Authors:  Leon A Sakkal; Kyle Z Rajkowski; Roger S Armen
Journal:  J Comput Chem       Date:  2017-01-28       Impact factor: 3.376

Review 5.  A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.

Authors:  Kenneth A Jacobson; Stefania Merighi; Katia Varani; Pier Andrea Borea; Stefania Baraldi; Mojgan Aghazadeh Tabrizi; Romeo Romagnoli; Pier Giovanni Baraldi; Antonella Ciancetta; Dilip K Tosh; Zhan-Guo Gao; Stefania Gessi
Journal:  Med Res Rev       Date:  2017-07-06       Impact factor: 12.944

Review 6.  Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.

Authors:  David R Janero; Ganesh A Thakur
Journal:  Expert Opin Drug Discov       Date:  2016-10-21       Impact factor: 6.098

7.  Characterization of Dual-Acting A3 Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gαi3 and GαoA Isoprotein Activation.

Authors:  Courtney L Fisher; Lucas B Fallot; Tina C Wan; Robert F Keyes; R Rama Suresh; Amy C Rothwell; Zhan-Guo Gao; John D McCorvy; Brian C Smith; Kenneth A Jacobson; John A Auchampach
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-15

8.  Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression.

Authors:  Mark J Wall; Emily Hill; Robert Huckstepp; Kerry Barkan; Giuseppe Deganutti; Michele Leuenberger; Barbara Preti; Ian Winfield; Sabrina Carvalho; Anna Suchankova; Haifeng Wei; Dewi Safitri; Xianglin Huang; Wendy Imlach; Circe La Mache; Eve Dean; Cherise Hume; Stephanie Hayward; Jess Oliver; Fei-Yue Zhao; David Spanswick; Christopher A Reynolds; Martin Lochner; Graham Ladds; Bruno G Frenguelli
Journal:  Nat Commun       Date:  2022-07-18       Impact factor: 17.694

9.  Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin.

Authors:  Rebekah L Bower; Lauren Yule; Tayla A Rees; Giuseppe Deganutti; Erica R Hendrikse; Paul W R Harris; Renata Kowalczyk; Zachary Ridgway; Amy G Wong; Katarzyna Swierkula; Daniel P Raleigh; Augen A Pioszak; Margaret A Brimble; Christopher A Reynolds; Christopher S Walker; Debbie L Hay
Journal:  ACS Pharmacol Transl Sci       Date:  2018-04-23

Review 10.  Molecular Simulations and Drug Discovery of Adenosine Receptors.

Authors:  Jinan Wang; Apurba Bhattarai; Hung N Do; Sana Akhter; Yinglong Miao
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.